BioSpace News Archive

Medical Economics®, a multimedia platform that provides resources for physicians that include practice management, health technology and expert voices, announces that its article Surviving Merger Mania: What Healthcare Consolidation Means for Physicians and Patients was recently named a Gold Award regional winner for the American Society of Business Publication Editors

CDISC and The Critical Path Institute (C-Path) are pleased to announce the release of a global Therapeutic Area Standard, which describes how to use CDISC standards to represent data in research studies pertaining to Clostridium difficile associated diarrhea (CDAD).

MindBytes BVBA and its subsidiary, MindLab Interactive AI Inc., (“MindBytes”) today announced that its first peer-reviewed manuscript was published in the open access journal JMIR Serious Games (JSG), a leading journal on gaming and gamification for health education, teaching, and social change.

A global data analytics and advisory firm, Quantzig, that delivers actionable analytics solutions to resolve complex business problems has announced the completion of their latest real world evidence engagement for a healthcare service provider.

Fast-growing women’s health care start-up, Kindbody, today announced that Annbeth Eschbach has joined as President and Debbie Markowitz as Chief Financial Officer.

The results of a new survey released last week at the 3rd Annual NASH (nonalcoholic steatohepatitis) Summit in Boston show that even among patients most at-risk for the fatty liver disease, awareness of the condition remains low.

McKesson Corporation (NYSE:MCK) today announced that it has settled litigation with the State of West Virginia to resolve all claims regarding McKesson’s operations in the state.

The Center for Health Affairs’ Board of Directors has named Brian Lane as its new president and CEO, effective May 15.

GlaxoSmithKline plc (LSE/NYSE: GSK) and Innoviva, Inc. (NASDAQ: INVA) today announced headline results from the pivotal phase III CAPTAIN study of once-daily single inhaler triple therapy Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol: FF/UMEC/VI) compared to Relvar/Breo Ellipta (FF/VI), in the treatment of patients living with uncontrolled asthma.

ConnXus and Robinson LaRueCo Consulting (RLC) have entered into a strategic partnership that delivers high quality supplier diversity engagement to the healthcare industry.